Erasca, Inc. NASDAQ:ERAS

Founder-led company

Erasca stock price today

$1.54
-1
-39.37%
Financial Health
0
1
2
3
4
5
6
7
8
9

Erasca stock price monthly change

-14.48%
month

Erasca stock price quarterly change

-14.48%
quarter

Erasca stock price yearly change

+18.14%
year

Erasca key metrics

Market Cap
696.92M
Enterprise value
119.87M
P/E
-1.42
EV/Sales
N/A
EV/EBITDA
-0.38
Price/Sales
N/A
Price/Book
0.84
PEG ratio
0.18
EPS
-0.84
Revenue
N/A
EBITDA
-140.45M
Income
-126.86M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Erasca stock price history

Erasca stock forecast

Erasca financial statements

Average Price Target
Last Year

$6

Potential upside: 289.61%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Erasca, Inc. (NASDAQ:ERAS): Profit margin
Jun 2023 0 -31.78M
Sep 2023 0 -30.36M
Dec 2023 5.58M -29.70M -532.28%
Mar 2024 0 -35.01M
Erasca, Inc. (NASDAQ:ERAS): Earnings per share (EPS)
2022-11-09 -0.31 -0.29
2023-03-23 -0.32 -1.06
2023-05-11 -0.3 -0.31
Erasca, Inc. (NASDAQ:ERAS): Debt to assets
Jun 2023 440662000 77.95M 17.69%
Sep 2023 419406000 80.43M 19.18%
Dec 2023 395297000 78.61M 19.89%
Mar 2024 370022000 81.61M 22.06%
Erasca, Inc. (NASDAQ:ERAS): Cash Flow
Jun 2023 -25.95M -108.66M 649K
Sep 2023 -24.12M -1.81M 7K
Dec 2023 -24.78M 4.54M 456K
Mar 2024 -33.25M 9.97M 6.93M

Erasca alternative data

Erasca, Inc. (NASDAQ:ERAS): Employee count
Aug 2023 129
Sep 2023 129
Oct 2023 129
Nov 2023 129
Dec 2023 129
Jan 2024 129
Feb 2024 129
Mar 2024 129
Apr 2024 129
May 2024 126
Jun 2024 126
Jul 2024 126

Erasca other data

16.87% -49.17%
of ERAS is owned by hedge funds
20.58M -59.19M
shares is hold by hedge funds

Erasca, Inc. (NASDAQ:ERAS): Insider trades (number of shares)
Period Buy Sel
Jun 2023 100000 0
Oct 2023 1000000 0
Dec 2023 1040000 0
May 2024 80000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
CASDIN ALEXANDER W. director
Common Stock 80,000 $2.27 $181,920
Purchase
START VALERIE DENISE HARDING director
Common Stock 10,000 $1.85 $18,480
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 278,150 $1.72 $478,418
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 721,850 $1.69 $1,217,761
Purchase
CASDIN ALEXANDER W. director
Common Stock 30,000 $1.66 $49,800
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 1,000,000 $2.03 $2,026,000
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 100,000 $2.75 $275,000
Purchase
CASDIN ALEXANDER W. director
Common Stock 20,000 $2.76 $55,240
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 100,000 $2.84 $284,000
Purchase
LIM JONATHAN E director, 10 perc.. Common Stock 60,000 $3.86 $231,420
Insider Compensation
Dr. Jonathan E. Lim (1972) Co-Founder, Chairman & Chief Executive Officer $480,000
Dr. David M. Chacko M.D. (1983) Chief Financial Officer
$455,300
Dr. Michael D. Varney Ph.D. (1958) Chairman of R&D, Scientific Advisory Board member and Director
$26,300
Friday, 15 November 2024
zacks.com
Tuesday, 12 November 2024
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Monday, 12 August 2024
globenewswire.com
Tuesday, 4 June 2024
zacks.com
Wednesday, 29 May 2024
globenewswire.com
Tuesday, 21 May 2024
globenewswire.com
Monday, 20 May 2024
https://seekingalpha.com
Thursday, 16 May 2024
globenewswire.com
globenewswire.com
Wednesday, 8 May 2024
globenewswire.com
Tuesday, 7 May 2024
globenewswire.com
Wednesday, 24 April 2024
globenewswire.com
Tuesday, 23 April 2024
Zacks Investment Research
Zacks Investment Research
Zacks Investment Research
Friday, 29 March 2024
Seeking Alpha
Wednesday, 3 January 2024
GlobeNewsWire
Wednesday, 20 December 2023
InvestorPlace
Friday, 8 December 2023
PennyStocks
Thursday, 7 December 2023
PennyStocks
Wednesday, 8 November 2023
GlobeNewsWire
Tuesday, 5 September 2023
GlobeNewsWire
Monday, 28 August 2023
Seeking Alpha
Monday, 14 August 2023
Seeking Alpha
Thursday, 25 May 2023
GlobeNewsWire
Tuesday, 16 May 2023
24/7 Wall Street
Wednesday, 8 February 2023
Seeking Alpha
Monday, 6 February 2023
Seeking Alpha
Wednesday, 1 February 2023
GlobeNewsWire
  • What's the price of Erasca stock today?

    One share of Erasca stock can currently be purchased for approximately $1.54.

  • When is Erasca's next earnings date?

    Unfortunately, Erasca's (ERAS) next earnings date is currently unknown.

  • Does Erasca pay dividends?

    No, Erasca does not pay dividends.

  • How much money does Erasca make?

    Erasca has a market capitalization of 696.92M. Erasca made a loss 125.04M US dollars in net income (profit) last year or -$0.31 on an earnings per share basis.

  • What is Erasca's stock symbol?

    Erasca, Inc. is traded on the NASDAQ under the ticker symbol "ERAS".

  • What is Erasca's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Erasca?

    Shares of Erasca can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Erasca's key executives?

    Erasca's management team includes the following people:

    • Dr. Jonathan E. Lim Co-Founder, Chairman & Chief Executive Officer(age: 53, pay: $480,000)
    • Dr. David M. Chacko M.D. Chief Financial Officer(age: 42, pay: $455,300)
    • Dr. Michael D. Varney Ph.D. Chairman of R&D, Scientific Advisory Board member and Director(age: 67, pay: $26,300)
  • Is Erasca founder-led company?

    Yes, Erasca is a company led by its founder Dr. Jonathan E. Lim.

  • How many employees does Erasca have?

    As Jul 2024, Erasca employs 126 workers, which is 2% less then previous quarter.

  • When Erasca went public?

    Erasca, Inc. is publicly traded company for more then 4 years since IPO on 16 Jul 2021.

  • What is Erasca's official website?

    The official website for Erasca is erasca.com.

  • Where are Erasca's headquarters?

    Erasca is headquartered at 10835 Road to the Cure, San Diego, CA.

  • How can i contact Erasca?

    Erasca's mailing address is 10835 Road to the Cure, San Diego, CA and company can be reached via phone at 858 465 6511.

  • What is Erasca stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for Erasca in the last 12 months, the avarage price target is $6. The average price target represents a 289.61% change from the last price of $1.54.

Erasca company profile:

Erasca, Inc.

erasca.com
Exchange:

NASDAQ

Full time employees:

126

Industry:

Biotechnology

Sector:

Healthcare

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

10835 Road to the Cure
San Diego, CA 92121

CIK: 0001761918
ISIN: US29479A1088
CUSIP: 29479A108